Mixed or borderline
DIME
Gao et al., JAMA Psychiatry, February 2026
Who was studied Depression — treatment-resistant
- What it tested
- The first proper randomised trial of this idea in depression. Eighty-eight UK adults aged 18 to 65 with a PHQ-9 score of 15 or more who had already tried at least two antidepressants without enough benefit. Six weeks on a ketogenic diet or on a carefully matched comparison diet, with everyone followed to twelve weeks.
- What it found
- At six weeks the ketogenic group improved more: a fall of 10.5 points on the PHQ-9 depression questionnaire against 8.3 in the comparison group. The adjusted difference between the groups was 2.18 points, with a confidence interval running from 4.33 down to 0.03 and a p-value of 0.05 — in other words, only just distinguishable from no difference at all. No serious adverse events occurred.
- What it cannot tell you
- By twelve weeks the gap between the groups had shrunk to 1.85 points and was no longer statistically significant. The authors describe the clinical relevance as uncertain, note the effect was modest and did not show up in most of the secondary measures, and report that fewer than one in ten participants managed to keep the diet going once the study support stopped. This is the strongest evidence that exists in depression, and it is a borderline six-week result that faded.
A ketogenic diet for treatment-resistant depression: a randomised clinical trial · registry NCT06091163